CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Induction of innate and adaptive immune responses after stopping NA therapy in HBeAg negative chronic hepatitis B
DOI 10.1055/s-0035-1568095
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Rinker, C Höner zu Siederdissen, CM Bremer, B Bremer, CS Falk, MP Manns, H Wedemeyer, D Glebe, ARM Kraft, M Cornberg
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe12/2015
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Stopping nucleos(t)ide analogue (NA) treatment before HBsAg loss is currently debated as a concept to induce HBsAg decline. In a prospective single center study we show that stopping NA treatment in HBeAg-negative patients is safe and leads to a significant decline of HBsAg. To understand mechanisms leading to HBsAg decline, the three HBV surface proteins (S-, L and MHBs), core-related antigen (HBcrAg), cytokine/che…
Zitieren
Zitierempfehlung
F Rinker, C Höner zu Siederdissen, CM Bremer, B Bremer, CS Falk, MP Manns, H Wedemeyer, D Glebe, ARM Kraft, M Cornberg (2015) Induction of innate and adaptive immune responses after stopping NA therapy in HBeAg negative chronic hepatitis B. Zeitschrift für Gastroenterologie (12). https://doi.org/10.1055/s-0035-1568095
Mit CareLit weiterarbeiten